Completed OBSERVATIONAL NCT06917846

Medical and Surgical Treatment of MRONJ (Medication-related Osteonecrosis of the Jaw Bones)

Is Medical Therapy Alone Efficient for the Management of Medication-Related Osteonecrosis of the Jaw Bones (MRONJ) in All Stages?: A Comparative Study

Sponsor: Akdeniz University

Conditions Osteonecrosis Due to Drugs, Jaw Osteonecrosis of the Jaw, Bisphosphonate Induced Osteonecrosis of the Jaw, Bisphosphonate Related

Updated 2 times since 2025 Last updated: Apr 4, 2025 Started: Jan 1, 2018 Primary completion: Jan 1, 2020 Completion: Jan 1, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06917846, this observational or N/A phase trial focuses on Osteonecrosis Due to Drugs, Jaw and Osteonecrosis of the Jaw, Bisphosphonate Induced and remains completed. Sponsored by Akdeniz University, it has been updated 2 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

2 versions recorded

Sep 2025 — Present [monthly]

Completed
May 2025 — Sep 2025 [monthly]

Completed

First recorded

Jan 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Akdeniz University

Data source: Akdeniz University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Antalya, Turkey (Türkiye)